Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2021-09-10 00:00:00 ET · period of report 2021-09-08 · accession 0001415889-21-004348 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-10 | 2021-09-08 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $28.20 | -2,577 | 162.4K | -2% | -$72.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-08 | F | D | 2,577 | $28.20 | 162,426 | D | — | — |